Ligand Pharmaceuticals Incorporated (LGND) — Net Asset Quality Index

Latest as of June 2026: 44.3%

Ligand Pharmaceuticals Incorporated (LGND) has a Net Asset Quality Index of 44.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $2.19 Billion minus total liabilities of $1.22 Billion yields net assets of $967.52 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read LGND total liabilities for a breakdown of total debt and financial obligations.

Quality Index

44.3%
Equity / Total Assets

Net Assets

$967.52 Million
USD

Total Assets

$2.19 Billion
USD

Total Liabilities

$1.22 Billion
USD

Ligand Pharmaceuticals Incorporated Net Asset Quality Index Over Time (1994–2025)

This chart shows how Ligand Pharmaceuticals Incorporated's Net Asset Quality Index has evolved across 32 annual periods from 1994 to 2025. As of June 2026, the index stands at 44.3%, representing net assets of $967.52 Million against total assets of $2.19 Billion USD. For live market cap and overall valuation, see Ligand Pharmaceuticals Incorporated market cap and net worth.

Annual Net Asset Quality Index for Ligand Pharmaceuticals Incorporated (1994–2025)

The table below presents the year-by-year Net Asset Quality Index for Ligand Pharmaceuticals Incorporated from 1994 to 2025, covering 32 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check LGND capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Year Quality Index Net Assets (USD) Total Assets Total Liabilities Change (pp)
2025 65.2% $1.02 Billion $1.56 Billion $543.42 Million ▼ -23.0 pp
2024 88.2% $830.44 Million $941.77 Million $111.33 Million ▼ -0.9 pp
2023 89.0% $700.91 Million $787.22 Million $86.30 Million ▲ +10.7 pp
2022 78.3% $597.49 Million $762.67 Million $165.18 Million ▲ +15.1 pp
2021 63.3% $821.16 Million $1.30 Billion $476.43 Million ▲ +11.2 pp
2020 52.1% $709.52 Million $1.36 Billion $652.76 Million ▲ +0.8 pp
2019 51.3% $767.23 Million $1.49 Billion $727.68 Million ▲ +6.8 pp
2018 44.5% $560.91 Million $1.26 Billion $699.89 Million ▼ -17.9 pp
2017 62.4% $418.65 Million $671.02 Million $252.37 Million ▲ +0.7 pp
2016 61.6% $370.85 Million $601.59 Million $230.73 Million ▲ +4.6 pp
2015 57.0% $304.39 Million $533.93 Million $229.54 Million ▲ +47.6 pp
2014 9.5% $24.41 Million $258.03 Million $233.62 Million ▼ -37.9 pp
2013 47.4% $49.61 Million $104.71 Million $55.10 Million ▲ +22.0 pp
2012 25.4% $26.48 Million $104.26 Million $77.78 Million ▲ +18.3 pp
2011 7.1% $8.65 Million $122.35 Million $113.70 Million ▲ +16.3 pp
2010 -9.3% $-6.99 Million $75.56 Million $82.55 Million ▼ -12.5 pp
2009 3.3% $3.74 Million $113.70 Million $109.95 Million ▲ +9.3 pp
2008 -6.0% $-10.37 Million $171.45 Million $181.81 Million ▼ -22.8 pp
2007 16.8% $29.11 Million $173.28 Million $144.16 Million ▲ +8.4 pp
2006 8.4% $27.35 Million $326.05 Million $298.70 Million ▲ +43.5 pp
2005 -35.1% $-110.42 Million $314.62 Million $425.04 Million ▼ -12.4 pp
2004 -22.7% $-75.32 Million $332.47 Million $407.78 Million ▼ -46.1 pp
2003 23.5% $70.73 Million $301.25 Million $230.53 Million ▼ -3.9 pp
2002 27.4% $74.02 Million $270.61 Million $196.59 Million ▲ +76.6 pp
2001 -49.3% $-57.88 Million $117.47 Million $175.35 Million ▼ -0.7 pp
2000 -48.6% $-55.12 Million $113.42 Million $168.55 Million ▼ -29.6 pp
1999 -19.0% $-25.60 Million $134.60 Million $160.20 Million ▼ -11.7 pp
1998 -7.3% $-11.40 Million $156.00 Million $167.40 Million ▼ -39.2 pp
1997 31.9% $34.30 Million $107.40 Million $73.10 Million ▼ -1.9 pp
1996 33.8% $34.50 Million $102.10 Million $67.60 Million ▲ +3.8 pp
1995 30.0% $28.10 Million $93.60 Million $65.50 Million ▼ -26.3 pp
1994 56.3% $26.30 Million $46.70 Million $20.40 Million
pp = percentage points